Member Info for NathanBryce

Interesting. Probably better news for Trilink that OMH, but at least it shows the company's out there doing stuff! Just waiting for the doom mongers to take the stage now, and tell us how this bit of info is 'worthless' and a sure indicator that Osmetech is destined for failure in the imminent future,. lol

First buy of the day just gone through at 2.6!

Yes indeedy! Buys coming back in towards 2.6 again! A real tonic!

Some confident buys today, and no sign of 2.5! Excellent!

that should read 'looking good here on the wards!

Yes, I think everyone's getting a little nervous down the building site! But things are looking food here on the wards. Heading back to 2.6 (but hopefully not before you get the chance to buy back in!).

Osmetech plc (OMH.L), the international molecular diagnostics company, announces that it has received a Medical Design Excellence Award for innovative device design. The Company has received a 2009 Medical Design Excellence Award for its eSensor® XT-8 molecular diagnostics platform, initially launched with a Warfarin Sensitivity Test. The FDA-cleared device produces results in less than 30 minutes detecting multiple genetic markers from a prepared patient sample. Using proprietary electro-chemical technology, the self-contained cartridge consumable contains 72 gold-plated electrodes, each acting as independent DNA microsensors on a printed circuit board. The instrument provides an easy-to-use graphical, touch screen interface, a small footprint, requires limited operator training, low maintenance and no instrument calibration. Each cartridge slot operates independently supporting the use of a wide variety of tests and the system's modular design enables the capacity requirements of high throughput users to be met. James White, Chief Executive Officer, Osmetech plc, said: "We are delighted that our eSensor XT-8 System and Warfarin Sensitivity Test has received this independent award. This is further recognition for our innovative, practical and cost-effective platform which is rapidly gaining market acceptance illustrated by our selection as principal supplier of Warfarin Sensitivity tests for a major n

We were chatting the other day about on-line trading - is your experience today an example of what can go wrong with that? I've got to say, I am seriously concerned about the building firm. Not sure whether to take my allocation or not. If the SP went anywhere below 25 between 19th May and 1st June, I'd be sick as the proverbial parrot! I realise this is not the BB to discuss this, but would value your opinion.

but by no means out!

Thanks for that!

Morning! Thanks for that RNS. Not entirely clear to me what has happened there - have Octopus gaines more shares, or what?

Are these trades buys?

Surely this news can only help bolster the company's application for emergency approval of their swine flu testing kit in the US? And if they run out of cash in July, wouldn't their recent activities make them a juicy buy-out target, possibly by an American outfit? http://www.londonstockexchange.com/LSECWS/IFSPages/MarketNewsPopup.aspx?id=2155218&source=RNS

No change whatsoever! But some very decent buys today. 2.55 seems to be the popular buy-in price at the moment, though there were a good few at 2.6. Looking forward to the rest of the week.

Yes - I believe the company is short of a bob or two. But then, so is Taylor Wimpey! See chrisgold's news bulletine a few posts back - that should bring in a few pennies, I would think!!!!!!

People are starting to talk!

What about a weekend in Bognor this Autumn?

Sorry about that!!!!

Could this be the 'Grand Rennaissance' of LMT?

MM manipulation to encourage buying.....?